Posted in Commercial With oral obesity race underway, all eyes are on Lilly’s Foundayo launch April 10, 2026 BioSpace Novo Nordisk’s oral Wegovy has a few months’ head start on Eli Lilly’s newly approved pill. CommercialMetabolic & GLP-1Read full story